Brentuximab Vedotin for Previously Untreated Peripheral T-cell Lymphpoma (ECHELON-2 trial) - New Standard of Care & Mantle Cell Lymphoma - Treatment and Review of Current Trials
By
Indy Hematology Review
FEATURING
John Leonard
By
Indy Hematology Review
FEATURING
John Leonard
Login to view comments.
Click here to Login